Literature DB >> 2550634

Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.

D Herpin1, D Conte.   

Abstract

The effect of lisinopril 20 mg given once daily was assessed in 25 patients with mild to moderate essential hypertension using both ambulatory monitoring and cuff measurements of blood pressure (BP) made in the clinic. The effect of 4 weeks of lisinopril treatment on BP was compared with the BP recorded after 2 weeks on placebo. Lisinopril treatment reduced supine and standing cuff clinic measurements of BP 24 h after dosing by (systolic/diastolic) 21.1/11.8 and 16.7/10.1 mmHg, respectively. Ambulatory measurements indicated that the antihypertensive effect of lisinopril was sustained throughout the 24 h without any significant effect on heart rate and that lisinopril did not affect the diurnal rhythm of BP changes. Side effects reported during the 4 weeks of lisinopril treatment were mild and did not necessitate discontinuation of treatment. Lisinopril appears to be an effective and well-tolerated antihypertensive agent when given in a single daily dose.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550634

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  11 in total

1.  Index Medicus and Canadian Family Physician.

Authors:  T Dixon
Journal:  Can Fam Physician       Date:  1993-01       Impact factor: 3.275

2.  Dermacase. Benign eccrine tumour (hidrocystoma).

Authors:  T Enta
Journal:  Can Fam Physician       Date:  1994-11       Impact factor: 3.275

3.  Dermacase. Eczema herpeticum.

Authors:  T Enta
Journal:  Can Fam Physician       Date:  1994-09       Impact factor: 3.275

4.  Family practice in Ontario. How physician demographics affect practice patterns.

Authors:  P G Norton; E V Dunn; L Soberman
Journal:  Can Fam Physician       Date:  1994-02       Impact factor: 3.275

5.  Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.

Authors:  C Bourgault; E Elstein; J Le Lorier; S Suissa
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

Review 6.  The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.

Authors:  C J Bulpitt; A E Fletcher; A Amery; J Coope; J G Evans; S Lightowlers; K O'Malley; A Palmer; J Potter; P Sever
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

Review 7.  Chronic fatigue syndrome. A fresh look at an old problem.

Authors:  J McSherry
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

Review 8.  Managing chronic pain in family practice.

Authors:  S L Librach
Journal:  Can Fam Physician       Date:  1993-03       Impact factor: 3.275

9.  Thrombolytic therapy for myocardial infarction. Treatment introduced in northern Ontario.

Authors:  P Hutten-Czapski
Journal:  Can Fam Physician       Date:  1993-05       Impact factor: 3.275

Review 10.  Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors?

Authors:  F Zannad
Journal:  Drugs       Date:  1993       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.